Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. [PDF]
Zequn Z +3 more
europepmc +1 more source
Integrating AI and Molecular Modeling for Structural Prediction of a Closed-Pore State of the hERG Channel. [PDF]
Upex C +4 more
europepmc +1 more source
Probucol-induced hERG Channel Reduction can be Rescued by Matrine and Oxymatrine in vitro. [PDF]
Shi YQ +6 more
europepmc +1 more source
α-mannosidase I-dependent N-linked glycosylation affects hERG channel functional availability during reactivation. [PDF]
Wei M +10 more
europepmc +1 more source
Modeling hERG Channel Liability: From Structural Insight to Highly Accurate Qualitative and Quantitative Models. [PDF]
Sun H, Wang Y, Shen M.
europepmc +1 more source
The PAS domain directly regulates hERG channel gating in patch-clamp fluorometry recordings. [PDF]
Trudeau MC.
europepmc +1 more source
The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine. [PDF]
El Harchi A +4 more
europepmc +1 more source
Insights into Hepatic, Neuronal, and hERG Channel Safety of Plant-Derived Active Compounds. [PDF]
Kasemnitichok Y +4 more
europepmc +1 more source
hERG Channel Blockade and Antagonistic Interactions of Three Steroidal Alkaloids from <i>Fritillaria</i> Species. [PDF]
Lu H +6 more
europepmc +1 more source
KCNH2-L693P Causes Long QT Syndrome Type 2 Through hERG Channel Dysfunction: Functional Validation of a Variant of Uncertain Significance. [PDF]
Zheng XF +4 more
europepmc +1 more source

